Related Experiment Video
Updated: Oct 4, 2025

Low-Cost, Volume-Controlled Dipstick Urinalysis for Home-Testing
Published on: May 8, 2021
ALK Testing Trends and Patterns Among Community Practices in the United States
Peter B Illei1, William Wong1, Ning Wu1
1Peter B. Illei, Johns Hopkins University School of Medicine, Baltimore, MD; William Wong, Laura Chu, Ravindra Gupta, and Katja Schulze, Genentech, South San Francisco; Matthew A. Gubens, University of California, San Francisco, CA; and Ning Wu, PRO Unlimited, Boca Raton, FL.
ALK testing in advanced non-small-cell lung cancer (NSCLC) increased over time. However, certain patient groups were less likely to be tested, indicating a need for further education on molecular diagnostics for ALK rearrangements.
Area of Science:
- Oncology
- Molecular Diagnostics
- Public Health
Background:
- Targeted therapy for anaplastic lymphoma kinase (ALK) rearrangements in metastatic non-small-cell lung cancer (NSCLC) improves patient outcomes.
- Real-world data on ALK testing patterns in community practices are crucial for understanding treatment accessibility.
Purpose of the Study:
- To assess real-world ALK testing patterns in advanced (stage IIIB or IV) NSCLC patients within US community practices.
- To identify demographic and clinical factors associated with ALK testing rates.
Main Methods:
- Analysis of electronic health records from the Flatiron Health database (January 2011–May 2017).
- Inclusion of patients aged ≥18 years with stage IIIB or IV NSCLC and at least two visits.
- Logistic regression to examine associations between patient characteristics and ALK testing.
Main Results:
- Over 53% of 31,483 NSCLC patients were tested for ALK rearrangements.
- ALK testing rates varied significantly by histology (66.9% nonsquamous vs. 18.5% squamous) and increased from 32.4% in 2011 to 62.1% in 2016.
- Older age, male sex, smoking history, non-Western US region, recurrent disease, squamous histology, and certain insurance types were associated with lower testing rates. 21.5% started therapy before results.
Conclusions:
- ALK testing rates in NSCLC have improved but remain suboptimal in specific patient subgroups.
- Educational initiatives are needed to promote molecular testing for ALK rearrangements in all eligible NSCLC patients.
- Addressing disparities in ALK testing is essential for equitable application of targeted therapies.
More Related Videos
Related Concept Videos
Testing Water Quality
Cochran's Q Test
Decision Making: Traditional Method
First, a specific claim about the population parameter is decided based on the research question and is stated in a simple form. Further, an opposing statement to this claim is also stated. These statements can act as null and alternative hypotheses, out of which a null hypothesis would be a...
Longitudinal Research
Surveys
Data Collection by Observations
An astronomer viewing the motion and brightness of stars in the sky and recording the data is an example of observational data collection. A botanist recording...

